Breast pathology: Beyond morphology

Seminars in Diagnostic Pathology

Volumn 27, Issue 1, 2010, Pages 91-96

  Simpson, Peter T ^a   Reis Filho, Jorge S ^b   Lakhani, Sunil R ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Breast; Cancer; Molecular pathology

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROTEIN P53; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORPHOLOGY; CARCINOMA IN SITU; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DISEASE MARKER; GENE EXPRESSION PROFILING; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DNA, NEOPLASM; FEMALE; GENOMICS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PROGNOSIS;

EID: 77349120983     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2009.12.001     Document Type: Article

References (79)

1. Ellis I.O., Galea M., Broughton N., et al. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992, 20:479-489.
2. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
3. Oldenhuis C.N., Oosting S.F., Gietema J.A., et al. Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer 2008, 44:946-953.
4. Azzopardi J.G. Problems in Breast Pathology 1979, W B Saunders Company LTD, London, United Kingdom.
5. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
6. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874.
7. Weigelt B., Baehner F.L., Reis-Filho J.S. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: A retrospective of the last decade. J Pathol 2009, 220:263-280.
8. Alizadeh A.A., Ross D.T., Perou C.M., et al. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 2001, 195:41-52.
9. Buerger H., Otterbach F., Simon R., et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999, 187:396-402.
10. Lakhani S.R. Is there a benign to malignant progression?. Endocr Relat Cancer 1997, 4:93-104.
11. Nishizaki T., Chew K., Chu L., et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997, 74:513-517.
12. Pollack J.R., Perou C.M., Alizadeh A.A., et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999, 23:41-46.
13. Reis-Filho J.S., Simpson P.T., Gale T., et al. The molecular genetics of breast cancer: The contribution of comparative genomic hybridization. Pathol Res Pract 2005, 201:713-725.
14. Simpson P.T., Reis-Filho J.S., Gale T., et al. Molecular evolution of breast cancer. J Pathol 2005, 205:248-254.
15. Chin K., DeVries S., Fridlyand J., et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10:529-541.
16. Natrajan R., Lambros M.B., Geyer F.C., et al. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?. Genes Chromosomes Cancer 2009, 48:351-365.
17. Natrajan R., Lambros M.B., Rodriguez-Pinilla S.M., et al. Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res 2009, 15:2711-2722.
18. Natrajan R, Weigelt B, Mackay A, et al: An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res Treat (in press).
19. Andre F., Job B., Dessen P., et al. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 2009, 15:441-451.
20. Buerger H., Otterbach F., Simon R., et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999, 189:521-526.
21. Buerger H., Simon R., Schafer K.L., et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000, 53:118-121.
22. Roylance R., Gorman P., Papior T., et al. A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene 2006, 25:6544-6553.
23. Stratton M.R., Collins N., Lakhani S.R., et al. Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 1995, 175:195-201.
24. Roylance R., Gorman P., Hanby A., et al. Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol 2002, 196:32-36.
25. Cleton-Jansen A.M., Buerger H., Haar N., et al. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 2004, 41:109-116.
26. Eusebi V., Magalhaes F., Azzopardi J.G. Pleomorphic lobular carcinoma of the breast: An aggressive tumor showing apocrine differentiation. Hum Pathol 1992, 23:655-662.
27. Middleton L.P., Palacios D.M., Bryant B.R., et al. Pleomorphic lobular carcinoma: Morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000, 24:1650-1656.
28. Palacios J., Sarrio D., Garcia-Macias M.C., et al. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol 2003, 16:674-678.
29. Simpson P.T., Gale T., Fulford L.G., et al. The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003, 5:258-262.
30. Sneige N., Wang J., Baker B.A., et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: A report of 24 cases. Mod Pathol 2002, 15:1044-1050.
31. Weidner N., Semple J.P. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 1992, 23:1167-1171.
32. Orvieto E., Maiorano E., Bottiglieri L., et al. Clinicopathologic characteristics of invasive lobular carcinoma of the breast: Results of an analysis of 530 cases from a Single Institution. Cancer 2008, 113:1511-1520.
33. Buchanan C.L., Flynn L.W., Murray M.P., et al. Is pleomorphic lobular carcinoma really a distinct clinical entity?. J Surg Oncol 2008, 98:314-317.
34. Simpson P., Reis-Filho J.S., Lambros M., et al. Molecular profiling pleomorphic lobular carcinomas of the breast: Evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 2008, 215:231-244.
35. Marchio C., Iravani M., Natrajan R., et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol 2008, 215:398-410.
36. Marchio C., Iravani M., Natrajan R., et al. Mixed micropapillary-ductal carcinomas of the breast: A genomic and immunohistochemical analysis of morphologically distinct components. J Pathol 2009, 218:301-315.
37. Reis-Filho J.S., Lakhani S.R. The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions. Breast Cancer Res 2003, 5:313-319.
38. Stange D.E., Radlwimmer B., Schubert F., et al. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin Cancer Res 2006, 12:345-352.
39. Derksen P.W., Liu X., Saridin F., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10:437-449.
40. Weigelt B., Geyer F.C., Natrajan R., et al. The molecular underpinning of lobular histological growth pattern: A genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol 2010, 220:45-57.
41. Cleton-Jansen A.M. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: Different genetic pathways in ductal and lobular breast cancer?. Breast Cancer Res 2002, 4:5-8.
42. Rakha E.A., Pinder S.E., Paish E.C., et al. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis. J Pathol 2004, 203:754-761.
43. Roylance R., Droufakou S., Gorman P., et al. The role of E-cadherin in low-grade ductal breast tumourigenesis. J Pathol 2003, 200:53-58.
44. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression datasets. Proc Natl Acad Sci USA 2003, 100:8418-8423.
45. Fulford L.G., Easton D.F., Reis-Filho J.S., et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 2006, 49:22-34.
46. Fulford L.G., Reis-Filho J.S., Ryder K., et al. Basal-like grade III invasive ductal carcinoma of the breast: Patterns of metastasis and long-term survival. Breast Cancer Res 2007, 9:R4.
47. Jones C., Ford E., Gillet C., et al. Molecular cytogenetic identification of sub-groups of grade III invasive ductal carcinomas with different clinical outcomes. Clin Cancer Res 2004, 10:5988-5997.
48. Rakha E.A., Reis-Filho J.S., Ellis I.O. Basal-like breast cancer: A critical review. J Clin Oncol 2008, 26:2568-2581.
49. Reis-Filho J.S., Milanezi F., Paredes J., et al. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 2003, 11:1-8.
50. Reis-Filho J.S., Milanezi F., Steele D., et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006, 49:10-21.
51. Reis-Filho J.S., Tutt A.N. Triple negative tumours: A critical review. Histopathology 2008, 52:108-118.
52. Rakha E.A., Tan D.S., Foulkes W.D., et al. Are triple negative tumours and basal-like breast cancer synonymous?. Breast Cancer Res 2007, 9:R80.
53. Farmer H., McCabe N., Lord C.J., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005, 434:917-921.
54. Hennessy B.T., Gonzalez-Angulo A.M., Stemke-Hale K., et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009, 69:4116-4124.
55. Weigelt B., Horlings H., Kreike B., et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008, 216:141-150.
56. Lim E., Vaillant F., Wu D., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009, 15:907-913.
57. Lakhani S., Collins N., Sloane J., et al. Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol 1995, 48:M74-M78.
58. Lakhani S.R., Collins N., Stratton M.R., et al. Atypical ductal hyperplasia of the breast: Clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995, 48:611-615.
59. Lu Y.J., Osin P., Lakhani S.R., et al. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998, 58:4721-4727.
60. O'Connell P., Pekkel V., Fuqua S.A., et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998, 90:697-703.
61. Aubele M.M., Cummings M.C., Mattis A.E., et al. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn Mol Pathol 2000, 9:14-19.
62. Jones C., Merrett S., Thomas V.A., et al. Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J Pathol 2003, 199:152-156.
63. Lakhani S.R., Slack D.N., Hamoudi R.A., et al. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 1996, 74:129-135.
64. Fraser J.L., Raza S., Chorny K., et al. Columnar alteration with prominent apical snouts and secretions: A spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 1998, 22:1521-1527.
65. Schnitt S.J., Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol 2003, 10:113-124.
66. Simpson P.T., Gale T., Reis-Filho J.S., et al. Columnar cell lesions of the breast: The missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 2005, 29:734-746.
67. Moinfar F., Man Y.G., Bratthauer G.L., et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): A simulator of normal mammary epithelium. Cancer 2000, 88:2072-2081.
68. Abdel-Fatah T.M., Powe D.G., Hodi Z., et al. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007, 31:417-426.
69. Abdel-Fatah T.M., Powe D.G., Hodi Z., et al. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 2008, 32:513-523.
70. Deng G., Lu Y., Zlotnikov G., et al. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996, 274:2057-2059.
71. Lakhani S.R., Chaggar R., Davies S., et al. Genetic alterations in "normal" luminal and myoepithelial cells of the breast. J Pathol 1999, 189:496-503.
72. Moinfar F., Man Y.G., Arnould L., et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res 2000, 60:2562-2566.
73. Ma X.J., Salunga R., Tuggle J.T., et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003, 100:5974-5979.
74. Tan D.S., Lambros M.B., Natrajan R., et al. Getting it right: Designing microarray (and not "microawry") comparative genomic hybridization studies for cancer research. Lab Invest 2007, 87:737-754.
75. Shah S.P., Morin R.D., Khattra J., et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813.
76. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
77. Aparicio S.A., Huntsman D.G. Does massively parallel DNA resequencing signify the end of histopathology as we know it?. J Pathol 2010, 220:307-315.
78. Ng S.B., Turner E.H., Robertson P.D., et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461:272-276.
79. Weigelt B., Reis-Filho J.S. Histological and molecular types of breast cancer: Is there a unifying taxonomy?. Nat Rev Clin Oncol 2009, 6:718-730.